Licio Collavin
Molecular Biology · 2012–2018
A researcher in the Science corpus: 2 papers; trusts 3 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 21 citations into it
- Oncology — 8 citations into it
- Cell Biology — 6 citations into it
Whom Licio Collavin trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Licio Collavin's perspective
Ordered by how strongly the researchers Licio Collavin trusts endorse each paper. Same corpus, a different order for every researcher.
- An Oncogene-Induced DNA Damage Model for Cancer Development (Science)
- Bortezomib or high-dose dexamethasone for relapsed multiple myeloma. (New England Journal of Medicine)
- Mutant p53 Disrupts Mammary Acinar Morphogenesis via the Mevalonate Pathway (Cell)
- DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis (Nature)
- DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. (Cell)
- Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome. (Cell)
- DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation (Nature)
- Histone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks (Nature Cell Biology)
- When mutants gain new powers: news from the mutant p53 field (Nature Reviews. Cancer)
- Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. (Methods)
Their papers
- Long non-coding antisense RNA controls Uchl1 translation through an embedded SINEB2 repeat (2012) — 929 citations
- Mutant p53 as a guardian of the cancer cell (2018) — 674 citations